HEB - Hemispherx Biopharma, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue92133197
Cost of Revenue1,1081,5981,251
Gross Profit-1,016-1,465-1,054
Operating Expenses
Research Development5,1078,0388,988
Selling General and Administrative7,6817,1479,057
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-13,804-16,650-19,099
Income from Continuing Operations
Total Other Income/Expenses Net6,3021,4231,660
Earnings Before Interest and Taxes-7,502-15,227-17,439
Interest Expense-311
Income Before Tax-7,502-15,230-17,450
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-7,502-15,230-17,450
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,502-15,230-17,450
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,502-15,230-17,450